SOPH
SOPHiA GENETICS SAHealthcare$5.04
◆ Neutral
Mkt Cap: $361.2M|Float: 52.5M|SI: 0.4%|DTC: 1.8
Data as of market close Apr 2, 2026
IV Rank
75
IV Pctl
44%
HV 20d
42.8%
52W Range
$3-$6
ATR(14)
$0.28
Exp. Move
±10.9%
P/C Ratio
0.08
Earnings
May 5
GEX Positive
DEX Long
Net Put Premium
IV High
Max Pain Below
Exp. Move Wide
Low Put/Call
SOPH Key Options Data
- IV Rank
- 74.9%
- Total GEX
- $0.00B
- Total DEX
- $0.1M
- Max Pain
- $5.00
- Expected Move
- ±10.9%
- Put/Call OI
- 0.08
- Net Premium
- $-0.0M
- Spot Price
- $5.04
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$0.55 | ±10.9% | $4.49 | $5.59 |
| 2026-06-18 | 77 | ±$1.75 | ±34.7% | $3.29 | $6.79 |
| 2026-09-18 | 169 | ±$1.22 | ±24.3% | $3.81 | $6.26 |
Explore SOPH options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.